Tudor Investment Corp
HOOK

Tudor Investment Corp’s HOOKIPA Pharma HOOK Stock Holding History

Tudor Investment Corp’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,000
Closed -$222K – 1691
2020
Q4 		$222K Buy
+2,000
New +$216K 0.01% 1208

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Tudor Investment Corp's HOOK Position: Q1 2021 in Review

Tudor Investment Corp sold out of HOOKIPA Pharma (HOOK) in Q1 2021, closing a stake of 2,000 shares — an estimated $222K sold.

Tudor Investment Corp first reported a position in HOOK in Q4 2020 and held it in 1 quarter. The position peaked at $222K in Q4 2020. 62 funds tracked by Wall St. Rank hold HOOK as of Q1 2021.

  • Tudor Investment Corp reported no remaining HOOKIPA Pharma position as of Q1 2021 after selling out during the quarter.
  • Tudor Investment Corp sold 2,000 HOOKIPA Pharma shares in Q1 2021, an estimated $222K.
  • Tudor Investment Corp first reported a position in HOOKIPA Pharma in Q4 2020 and held it in 1 quarter.
  • Tudor Investment Corp's HOOKIPA Pharma position peaked at $222K in Q4 2020.
  • 62 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2021.

Based on Tudor Investment Corp's 13F filing for Q1 2021, filed 17 May 2021.